Drug Type Live attenuated vaccine, Prophylactic vaccine |
Synonyms BS 032VX HSV2 attenuated vaccine(Wuhan Binhui Biotechnology), BS-032VX herpes simplex virus 2 vaccine, HSV2-gD mRNA vaccine (Wuhan Binhui Biotechnology Co.,Ltd.) + [2] |
Target |
Action inhibitors, stimulants |
Mechanism HSV gD inhibitors(HSV gD inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Herpesviridae Infections | IND Application | China | - | |
Herpes Simplex | Preclinical | China | 22 Oct 2024 |